Valuation DexCom, Inc. BOERSE MUENCHEN
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.40 EUR | 0.00% |
|
+9.17% | +12.63% |
| 07-03 | Dexcom Recalls Certain Lots of Dexcom G7 Continuous Glucose Monitoring System Sensors | CI |
| 07-03 | Alert from law firm on Dexcom withdrawn | RE |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 28,389 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 9.67% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 27,984 | 27,177 | 26,168 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 6.77% | -2.88% | -3.72% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 30.1x | 25.2x | 21x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 10.4x | 8.92x | 6.8x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.3x | 1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.43x | 4.87x | 4.37x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.36x | 4.67x | 4.03x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.1x | 14.2x | 11.9x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 23.1x | 18.9x | 15.2x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 28.2x | 21.9x | 17.3x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.55% | 4.57% | 5.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,826 | 6,501 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,639 | 1,913 | 2,205 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,723 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -405 | -1,211 | -2,221 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 73.57 | 73.57 | 73.57 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.7x | 3.55x | 13.32x | 2.66% | 167B | |
| 19x | 3.31x | 11.66x | 3.54% | 107B | |
| 16.74x | 0.19x | 11.96x | 0.78% | 59.24B | |
| 32.42x | 7.87x | 20.57x | 1.24% | 52.99B | |
| 38.95x | 3.07x | 10.55x | 2.46% | 43.07B | |
| 41.17x | 1.48x | 12.99x | 0.19% | 36.37B | |
| 42.29x | 7.33x | 26.44x | 0.25% | 25.16B | |
| 20.54x | 2.83x | 11.03x | 1.53% | 21.17B | |
| 23.7x | 3.47x | 12.45x | 1.22% | 20.99B | |
| Average | 28.72x | 3.68x | 14.55x | 1.54% | 59.25B | |
| Weighted average by Cap. | 26.02x | 3.53x | 13.80x | 2.09% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
